The treatment is simple.
The diagnosis is the art.
We teach the system behind it.
The Rayess-Schoening Technique combines Dr. Adel Rayess's manual primary lesion diagnostics with the NeuroNJect technique developed by Florian Schöning — a diagnostic system you learn in a structured, small group, exactly as they apply it themselves. Taught publicly for the first time after 28 years of private, one-to-one teaching.
Watch the method in action.
Documented treatment cases from Dr. Adel Rayess's clinic and Florian Schoening's practice.
YouTube Privacy-Enhanced Mode & Vimeo DoNotTrack · no tracking without a click
Individual case reports — results may vary
„Ich werde es sofort am Montag umsetzen.“
„Beim ersten Kurs war ich sprachlos, habe es schon in der Praxis am nächsten Tag umsetzen können.“
Two technicians. One method.
Dr. Adel Rayess
The world's best-known clinical osteopath. Founder of the primary lesion methodology and the NeuroSPINE method. Studied in Switzerland (University of Lugano). Runs the largest private clinic in Lebanon — with waiting lists of up to 7 months. For 28 years he passed on his diagnostics only in person — to a handful of students in his own clinic. With NeuroSPINE he opens it up for the first time to trained practitioners: structured, in a small group, exactly as he applies it himself. Why only now? A single practitioner cannot reach more patients than he already does — what he can do is train practitioners who diagnose the way he does. NeuroSPINE is the format he has waited 28 years for.
Florian Schöning
Developer and trainer of the NeuroNJect technique. Physiotherapist (B.A., M.Sc. Sports Physiotherapy, German Sport University Cologne) and Heilpraktiker with around 20 years of professional experience, additionally trained in osteopathy, chiropractic and acupuncture — backed by 120+ continuing education courses in Germany and abroad. Co-founder of NeuroSPINE. Focus areas: manual medicine, functional neurology, neural therapy and neuromodulation. Physiotherapist to the German Basketball Federation since 2018, and regularly shares his knowledge through internal and external training courses. Complements Dr. Rayess's diagnostics with the perineural injection layer.
„Also ich habe schon viele Kurse gemacht, viele auch mit dir zusammen, aber das war bis jetzt der beeindruckendste.“
„Es ist eine tolle Kombination zu all meinen Methoden, die ich bisher verwende … ein wichtiger Baustein in Zukunft in meiner Praxis.“
The site of pain is rarely the site of the problem.
Some cases resolve faster than expected — not because the treatment is new, but because the diagnosis was more precise. The Rayess-Schoening Technique gives you the diagnostic tool to identify the true origin of a pain pattern before you treat: the manual identification of the original lesion — and the targeted calming of the irritated nerve.
The Primary Lesion
Modern medicine often treats the smoke (symptoms) and ignores the fire (the origin). The primary lesion is the original trauma in fascia and joints that triggers the pain chain — often far away from where the pain is felt. Find and correct it, and you topple the first domino: the nervous system can reorganize itself.
NeuroNJect
Perineural infiltration with 5% dextrose (D5W) at the Valleix points: a 30G subcutaneous technique that, according to current research, can contribute to calming neuropathic pain signals — without cortisone, without anesthetics. Developed and taught by Florian Schöning.
What doctors say after three days.
Original quotes from participants of past trainings — verbatim, untranslated.
Individual case reports — results may vary
„Phenomenal, unbelievable. Amazing quality, how many great people I have met here. It is worth 3-fold or 4-fold the price.“
Dr. Carmen Putz
Physician · Illmitz, Austria
„Excellent training — the combination of osteopathic techniques and perineural dextrose-infiltration leading to amazing results.“
Dr. Simon Yu
Physician · St. Louis, USA
„Unique, amazing — absolutely convinced to be able to use it on Monday in my clinic.“
Dr. Iris Prethaler
General practitioner · Kitzbühel, Austria
„The most impressive of all of them. So simple tools that we can use on a daily basis.“
Dr. Sieghard Glanzer
ENT specialist · Villach, Austria
„The combination of Primary Lesion and NeuroNJect is marvellous. A new perspective.“
Dr. Atel Hemat
Internist · Cologne, Germany
„We all got treatment, lots of treatment — normally I would pay more for my treatments than the training costs.“
Dr. Renate Thiele
Holistic medicine physician · President of the OZONE Society · Austria
„I got many new tools as add-on to my neuromodulation speciality to help people.“
Dr. Runa Rahman-Oshiga
General practitioner · Neuromodulation · Vienna, Austria
„I have integrated Primary Lesion in the FMD technique — it is very, very interesting.“
Dr. Peter Brunner
Expert in functional muscle diagnostics · Linz, Austria
„The best example what this training is doing.“
Dr. Hans Schönberger
Allgemeinmediziner · Bayrischzell, Deutschland
From Apprentice to Grand Master.
Certifications are valid for 2 years and are renewed through documented clinical results. Certified practitioners are listed in the public specialists directory.
Certified NeuroSPINE Practitioners worldwide
4 certified practitioners in 4 countries — every point on the map is a practice applying the method.
The next {max} seats won't last.
What happens if you change nothing? In five years, the same chronic cases will still sit in your waiting room — treated at the site of pain instead of the origin. Participants of this seminar go home with a diagnostic system that reopens exactly these cases. We allocate a maximum of 20 seats per cohort. Your seat is confirmed immediately upon payment — all details follow straight to your inbox.
„Ja, 100 Prozent.“
1 · Choose your seat
Pick a payment option and complete your booking — done in a few minutes.
2 · Confirmed instantly
Your seat is firmly reserved upon payment — no review process, no waiting.
3 · All the details
Travel info, materials and the schedule follow straight to your inbox.
Two cohorts already held in Vienna — February 2026 with 25 participants, a second round in May.
4+ graduates worldwide